Christof von Eiff, Frank Kipp, Karsten Becker. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, IntranasalAnti-Bacterial Agents/therapeutic useAntibiotic ProphylaxisCross Infection/prevention & controlDrug Resistance, BacterialHumansMupirocin/therapeutic useNose/microbiologyRisk FactorsStaphylococcal Infections/prevention & controlStaphylococcus aureus/isolation & purificationSurgical Wound Infection/prevention & control
Substances: See more » Anti-Bacterial AgentsMupirocin
Year: 2002 PMID: 12374887 DOI: 10.1056/NEJM200210103471518
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245